Yan-Jun Xiang (Yanjun Xiang)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 17

Top Topics

Tyrosine Kinase

Metastatic Colorectal Cancer

Top Venues

Nature medicine

Journal of oncology

Future oncology (London, England)

Journal of hepatocellular carcinoma

This page only lists publications with an associated author ORCID identifier.

Publications

Yitao Zheng, Yan-Jun Xiang, Hongqi Shi, Zhuoqun Lin, Shuqun Cheng, Jiuting Zhu
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate-stage Hepatocellular Carcinoma: A Multicenter Retrospective Study. Journal of hepatocellular carcinoma 11 (2024)
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu, Ying-Yi Qin, Jie Shi, Wei-Xing Guo, Chong-De Lu, Ya-Xin Zheng, Fei-Guo Zhou, Mao-Lin Yan, Hong-Kun Zhou, Chao Liang, Fan Zhang, Wen-Jing Wei, Wan Yee Lau, Jing-Jing Li, Yan-Fang Liu, Shu-Qun Cheng
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial. Nature medicine 30 (3) (2024)
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu, Ying-Yi Qin, Jie Shi, Wei-Xing Guo, Chong-De Lu, Ya-Xin Zheng, Fei-Guo Zhou, Mao-Lin Yan, Hong-Kun Zhou, Chao Liang, Fan Zhang, Wen-Jing Wei, Wan Yee Lau, Jing-Jing Li, Yan-Fang Liu, Shu-Qun Cheng
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial. Nature medicine 30 (3) (2024)
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu, Ying-Yi Qin, Jie Shi, Wei-Xing Guo, Chong-De Lu, Ya-Xin Zheng, Fei-Guo Zhou, Mao-Lin Yan, Hong-Kun Zhou, Chao Liang, Fan Zhang, Wen-Jing Wei, Wan Yee Lau, Jing-Jing Li, Yan-Fang Liu, Shu-Qun Cheng
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial. Nature medicine (2024)
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu, Ying-Yi Qin, Jie Shi, Wei-Xing Guo, Chong-De Lu, Ya-Xin Zheng, Fei-Guo Zhou, Mao-Lin Yan, Hong-Kun Zhou, Chao Liang, Fan Zhang, Wen-Jing Wei, Wan Yee Lau, Jing-Jing Li, Yan-Fang Liu, Shu-Qun Cheng
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial. Nature medicine 30 (3) (2024)
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu, Ying-Yi Qin, Jie Shi, Wei-Xing Guo, Chong-De Lu, Ya-Xin Zheng, Fei-Guo Zhou, Mao-Lin Yan, Hong-Kun Zhou, Chao Liang, Fan Zhang, Wen-Jing Wei, Wan Yee Lau, Jing-Jing Li, Yan-Fang Liu, Shu-Qun Cheng
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial. Nature medicine (2024)
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu, Ying-Yi Qin, Jie Shi, Wei-Xing Guo, Chong-De Lu, Ya-Xin Zheng, Fei-Guo Zhou, Mao-Lin Yan, Hong-Kun Zhou, Chao Liang, Fan Zhang, Wen-Jing Wei, Wan Yee Lau, Jing-Jing Li, Yan-Fang Liu, Shu-Qun Cheng
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial. Nature medicine (2024)
Yitao Zheng, Yan-Jun Xiang, Hongqi Shi, Zhuoqun Lin, Shuqun Cheng, Jiuting Zhu
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate-stage Hepatocellular Carcinoma: A Multicenter Retrospective Study. Journal of hepatocellular carcinoma 11 (2024)
Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan-Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shu-Qun Cheng
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study. Journal of oncology 2023 (2023)
Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan-Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shu-Qun Cheng
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study. Journal of oncology 2023 (2023)
Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan-Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shu-Qun Cheng
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study. Journal of oncology 2023 (2023)
Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan-Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shu-Qun Cheng
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study. Journal of oncology 2023 (2023)
Ji Xia, Ning Ma, Qian Shi, Qin-Cheng Liu, Wei Zhang, Hui-Jun Cao, Yi-Kang Wang, Qian-Wen Zheng, Qian-Zhi Ni, Sheng Xu, Bing Zhu, Xiao-Song Qiu, Kai Ding, Jing-Yi Huang, Xin Liang, Yu Chen, Yan-Jun Xiang, Xi-Ran Zhang, Lin Qiu, Wei Chen, Dong Xie, Xiang Wang, Lingyun Long, Jing-Jing Li
XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis. The Journal of cell biology 223 (2) (2023)
Kang Wang, Hong-Ming Yu, Yan-Jun Xiang, Yu-Qiang Cheng, Qian-Zhi Ni, Wei-Xing Guo, Jie Shi, Shuang Feng, Jian Zhai, Shu-Qun Cheng
Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial. Future oncology (London, England) (2023)
Yan-Jun Xiang, Kang Wang, Hong-Ming Yu, Miao-Miao Wang, Le-Qun Li, Hui-Chuan Sun, Tian-Fu Wen, Yu-Qing Zhang, Yun-Feng Shan, Li-Ping Zhou, Shu-Qun Cheng
Hazard rate for postoperative recurrence in patients with hepatocellular carcinoma at Barcelona Clinic Liver Cancer stage 0 or A1: A multicenter observational study. Hepatology research : the official journal of the Japan Society of Hepatology 52 (11) (2022)
Yan-Jun Xiang, Kang Wang, Hong-Ming Yu, Xiao-Wei Li, Yu-Qiang Cheng, Wei-Jun Wang, Jin-Kai Feng, Meng-Han Bo, Ying-Yi Qin, Yi-Tao Zheng, Yun-Feng Shan, Li-Ping Zhou, Jian Zhai, Shu-Qun Cheng
Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 52 (8) (2022)
Kang Wang, Hong-Ming Yu, Yan-Jun Xiang, Yu-Qiang Cheng, Qian-Zhi Ni, Wei-Xing Guo, Jie Shi, Shuang Feng, Jian Zhai, Shu-Qun Cheng
Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial. Future oncology (London, England) 18 (30) (2022)